Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation [NA]
A clinical trial evaluating trigeminal nerve stimulation for anxiety disorders is currently active but not recruiting. The conditions includ…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder [Phase 2]
Phase 2 clinical trial evaluating dietary counseling plus omega-3 supplementation for Generalized Anxiety Disorder; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression [NA]
This clinical trial is recruiting adolescents to evaluate a transdiagnostic internet-delivered intervention for anxiety and depressive disor…
-
FDA approval · 2025-03-28FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental ANDA for a duloxetine hydrochloride delayed-release product, making a generic du…
-
CLINICAL_TRIALS other · 2025-03-27Clinical Trial Update: ACT for Mental Health in Neurological Disorders [NA]
Clinical trial update for ACT (Acceptance and Commitment Therapy) targeting mental health in neurological disorders shows the study is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms [Phase 2]
A Phase 2 dose-finding trial of MM120 (LSD D-tartrate) for generalized anxiety disorder has completed enrollment with results posted.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
A clinical trial update indicates Psyrin Inc. is enrolling participants to test a speech-based machine learning algorithm that aims to predi…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD) [Phase 1]
A Phase 1 study assessing the pharmacokinetics, safety, and tolerability of ABBV-932 in healthy volunteers and in individuals with generaliz…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population [NA]
This clinical trial update reports the initial feasibility and efficacy assessment of a scalable digital cognitive behavioral therapy for ge…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Digital Interventions As an Add-on Tool in Generalized Anxiety Disorder Treatment [NA]
Completed clinical trial evaluating digital interventions as an add-on tool for Generalized Anxiety Disorder.
-
FDA approval · 2025-03-13FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) as a generic product under NorthStar Rx LLC's ANDA.
-
FDA approval · 2025-03-13FDA Approved: BUCAPSOL — Original Application (PANGEA PHARMACEUTICALS, LLC)
FDA approved BUCAPSOL, a generic buspirone hydrochloride product, under an Original Abbreviated New Drug Application by PANGEA PHARMACEUTICA…
-
FDA approval · 2025-03-05FDA Approved: ESCITALOPRAM — Supplemental Application (SOLCO HEALTHCARE US, LLC)
The FDA granted a supplemental approval for escitalopram (generic) from Solco Healthcare US, LLC under an ANDA.
-
FDA approval · 2025-02-28FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, adding regulatory approval for this ge…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Reducing Symptoms of Depression, Stress and Anxiety and Enhancing Positive Mental Health: a Randomized-controlled Study of the Positive Emotions Training [NA]
A randomized-controlled study evaluating Positive Emotions Training to reduce symptoms of depression, stress, and anxiety and to enhance pos…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care [NA]
A recruiting study from Portland State University tests an intervention to improve coping and help-seeking among youth in foster care. The s…
-
FDA approval · 2025-02-21FDA Approved: PREGABALIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved a generic pregabalin product from Torrent Pharmaceuticals Limited (ANDA 206942) to be used for the same indications as the refe…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder [NA]
A clinical trial evaluating EEG-based neurophysiological and psychological effects of Ericksonian hypnotherapy in Generalized Anxiety Disord…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Digital Versus Hybrid Interventions in Promoting Nutrition Knowledge Among Saudi Adolescent Girls [NA]
A completed clinical trial comparing digital versus hybrid interventions aimed at improving nutrition knowledge among Saudi adolescent girls…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Potency and Precision Investigation [NA]
A completed clinical trial sponsored by Woebot Health evaluating potency and precision, with results posted on 2025-02-19, focusing on depre…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD [NA]
A clinical trial comparing short-term psychoanalytic therapy to cognitive behavioral therapy for Generalized Anxiety Disorder, currently rec…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Partners in Caring for Anxious Youth [Phase 3]
An update on a Phase 3 clinical trial for anxious youth, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Investigating the Impacts of Early Life Experience on the Brain & Behaviour
The University of Manchester reports an ongoing recruiting study investigating how early life experiences influence brain and behavior relat…
-
FDA approval · 2025-02-11FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine (Padagis US LLC), updating the labeling to reflect expanded indications for the antid…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Implementation of Internet-based Psychotherapy for Symptoms of Depression, Insomnia and Anxiety in Primary Care in the Cities of Indaiatuba and Jaguariuna [NA]
Clinical trial update on implementing internet-based psychotherapy for depression, insomnia, and anxiety in primary care in Indaiatuba and J…